Biogen looks to M&A to overcome competition to its MS franchise | Fierce Pharma
Carla Erba - Latam PSP Lead - Biogen | LinkedIn
AbbVie Discontinued a Drug Trial. Biogen Stock Is Falling. | Barron's
Carla Erba - Latam PSP Lead - Biogen | LinkedIn
Cure PSP - Can Progressive Supranuclear Palsy (PSP) be treated at all? The PASSPORT trial is investigating whether a new investigational study drug may slow the progression of PSP. Biogen plan to
Biogen Reports Top-Line Results from Phase 2 Study in Progressive Supranuclear Palsy | Biogen
Corio PSP™ – Detox RejuveNation
PSPH (Human) Recombinant Protein (Q01) - BIOGEN Científica
admin – Page 2 – PSP Society of Canada
Biogen on Twitter: "#DYK progressive supranuclear palsy (#PSP) wasn't discovered until 1963 due to its resemblance to Parkinson's disease? #PSPAwarenessMonth https://t.co/59rxSezyHe" / Twitter
After Recent Tau Failure, Biogen Licenses Tau Therapeutic from Ionis for Alzheimer's Disease | BioSpace
FAQ on FDA Approval of Aducanumab - CurePSP
Biogen chalks up another failure, but investors' eyes remain firmly on Alzheimer's | Fierce Biotech
Biogen on Twitter: "Chris Henderson, VP, Neuromuscular and Movement Disorders Research Unit, highlights the importance of an early Progressive Supranuclear Palsy (PSP) diagnosis #PSPAwareness https://t.co/xDnZaZYYhT" / Twitter
Biogen MA Inc. 225 Binney Street Cambridge, MA 02142 United States PROTOCOL NUMBER: 251PP301 / NCT03068468 Biogen Idec Research
Medscape Neurology - After disappointing trial results, Biogen will discontinue development of gosuranemab for PSP and other primary tauopathies. http://ms.spr.ly/6182Tn3Cq | Facebook
Programa de apoyo a pacientes (22/11/2022) – AEFI – Área Multimedia
Biogen MA Inc. 225 Binney Street Cambridge, MA 02142 United States PROTOCOL NUMBER: 251PP301 / NCT03068468 Biogen Idec Research
Biogen | Contract Pharma
Biogen Study - CurePSP
Biogen on Twitter: "We'll be showcasing our work in neuroscience including the areas of multiple sclerosis (#MS), spinal muscular atrophy (#SMA), Alzheimer's Disease (#AD) and progressive supranuclear palsy (#PSP) with poster and
PSP — Coleen Heaver
Acompañamos a... - Pharmexx Argentina part of Ashfield Group | Facebook
NS Innovation: la cumbre en neurociencias que cambiará la vida de millones de pacientes - Infobae
